Targeting cancer cells with transferrin conjugates containing the non-toxic type 2 ribosome-inactivating proteins nigrin b or ebulin l

Cancer Letters

Volumn 184, Issue 1, 2002, Pages 29-35

  Citores, Lucı́a ^a,b   Miguel Ferreras, J ^a,b   Muñoz, Raquel ^a,b   Benı́tez, Jorge ^a,b   Jiménez, Pilar ^a,b   Girbés, Tomás ^a,b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cancer therapy; Ebulin l; HeLa cells; Nigrin b; Ribosome inactivating proteins; Transferrin conjugates

Indexed keywords

RICIN; TRANSFERRIN; TRANSFERRIN EBULIN 1 CONJUGATE; TRANSFERRIN NIGRIN B CONJUGATE; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; EBULIN R PROTEIN, SAMBUCUS EBULUS; GLYCOSIDASE; PROTEIN SYNTHESIS INHIBITOR; RIBOSOME INACTIVATING PROTEIN TYPE 2, SAMBUCUS; RIBOSOME-INACTIVATING PROTEIN TYPE 2, SAMBUCUS; VEGETABLE PROTEIN;

ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DERIVATIZATION; DRUG CONJUGATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; ANIMAL; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; HELA CELL; METABOLISM; RABBIT;

ANIMAL; COMPARATIVE STUDY; DRUG DELIVERY SYSTEMS; HELA CELLS; HUMAN; N-GLYCOSYL HYDROLASES; PLANT PROTEINS; PROTEIN SYNTHESIS INHIBITORS; RABBITS; RECEPTORS, TRANSFERRIN; SUPPORT, NON-U.S. GOV'T; TRANSFERRIN; ANIMALS; HUMANS;

EID: 0037044183     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00169-6     Document Type: Article

References (25)

1. Targeted toxins
2. Immunotoxins in cancer therapy
3. Ribosome-inactivating proteins from plants
4. Recent advances in the uses and applications of ribosome-inactivating proteins from plants
5. Anti-transferrin receptor monoclonal antibody and toxin-antibody conjugates affect growth of human tumour cells
6. Vascular protection by chloroquine during brain tumor therapy
7. Targeted toxin therapy for malignant astrocytoma
8. Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by anti-transferrin recombinant immunotoxin
9. Transferrin as a targeting ligand for liposomes and anticancer drugs
10. Toxic lectins and related proteins
11. An immunotoxin prepared with blocked ricin: A natural plant toxin adapted for therapeutic use
12. Anti-B4-blocked ricin: A phase II trial of 7 day continuous infusion in patients with multiple myeloma
13. A phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphoma
14. In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiple
15. Potent and specific killing of malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin
16. Isolation and partial characterization of nigrin b, a non-toxic novel type 2 ribosome-inactivating protein from the bark of Sambucus nigra L.
17. Ebulin l, a non-toxic novel type 2 ribosome-inactivating protein from Sambucus ebulus L. leaves
18. Ribosome-inactivating proteins and lectins from Sambucus
19. Sensitivity of several cancer cell lines to ricin and the novel type 2 ribosome-inactivating protein nigrin b
20. Differences in cytotoxicity of native and engineered RIPs can be used to assess their ability to reach the cytoplasm
21. The 2.8 Å crystal structure of a nontoxic type-II ribosome-inactivating protein, ebulin l
22. Immunotoxin sensitivity of Chinese hamster ovary cells expressing human transferrin receptors with differing internalization rates
23. A chimeric saporin-transferrin conjugate compared to ricin toxin: Role of the carrier in intracellular transport and toxicity
24. Mistletoe lectins are strong mucosal adjuvants
25. The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: Insights into toxin-mediated vascular damage